These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 15233948)
1. Naked DNA transfer of Factor VIII induced transgene-specific, species-independent immune response in hemophilia A mice. Ye P; Thompson AR; Sarkar R; Shen Z; Lillicrap DP; Kaufman RJ; Ochs HD; Rawlings DJ; Miao CH Mol Ther; 2004 Jul; 10(1):117-26. PubMed ID: 15233948 [TBL] [Abstract][Full Text] [Related]
2. Immunomodulation of transgene responses following naked DNA transfer of human factor VIII into hemophilia A mice. Miao CH; Ye P; Thompson AR; Rawlings DJ; Ochs HD Blood; 2006 Jul; 108(1):19-27. PubMed ID: 16507778 [TBL] [Abstract][Full Text] [Related]
3. High-level factor VIII gene expression in vivo achieved by nonviral liver-specific gene therapy vectors. Miao CH; Ye X; Thompson AR Hum Gene Ther; 2003 Sep; 14(14):1297-305. PubMed ID: 14503965 [TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia A mice compared with factor VIII protein infusion. Bristol JA; Gallo-Penn A; Andrews J; Idamakanti N; Kaleko M; Connelly S Hum Gene Ther; 2001 Sep; 12(13):1651-61. PubMed ID: 11535168 [TBL] [Abstract][Full Text] [Related]
5. Partial correction of murine hemophilia A with neo-antigenic murine factor VIII. Sarkar R; Gao GP; Chirmule N; Tazelaar J; Kazazian HH Hum Gene Ther; 2000 Apr; 11(6):881-94. PubMed ID: 10779165 [TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cells encoding porcine factor VIII induce pro-coagulant activity in hemophilia A mice with pre-existing factor VIII immunity. Doering CB; Gangadharan B; Dukart HZ; Spencer HT Mol Ther; 2007 Jun; 15(6):1093-9. PubMed ID: 17387335 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains. Rawle FE; Shi CX; Brown B; McKinven A; Tinlin S; Graham FL; Hough C; Lillicrap D J Gene Med; 2004 Dec; 6(12):1358-68. PubMed ID: 15493040 [TBL] [Abstract][Full Text] [Related]
8. Transient B cell depletion or improved transgene expression by codon optimization promote tolerance to factor VIII in gene therapy. Sack BK; Merchant S; Markusic DM; Nathwani AC; Davidoff AM; Byrne BJ; Herzog RW PLoS One; 2012; 7(5):e37671. PubMed ID: 22655063 [TBL] [Abstract][Full Text] [Related]
9. Characterization of Adeno-Associated Viral Vector-Mediated Human Factor VIII Gene Therapy in Hemophilia A Mice. Greig JA; Wang Q; Reicherter AL; Chen SJ; Hanlon AL; Tipper CH; Clark KR; Wadsworth S; Wang L; Wilson JM Hum Gene Ther; 2017 May; 28(5):392-402. PubMed ID: 28056565 [TBL] [Abstract][Full Text] [Related]
10. A Treg-Selective IL-2 Mutein Prevents the Formation of Factor VIII Inhibitors in Hemophilia Mice Treated With Factor VIII Gene Therapy. Chen AC; Cai X; Li C; Khoryati L; Gavin MA; Miao CH Front Immunol; 2020; 11():638. PubMed ID: 32411127 [TBL] [Abstract][Full Text] [Related]
11. In vivo expansion of regulatory T cells with IL-2/IL-2 mAb complexes prevents anti-factor VIII immune responses in hemophilia A mice treated with factor VIII plasmid-mediated gene therapy. Liu CL; Ye P; Yen BC; Miao CH Mol Ther; 2011 Aug; 19(8):1511-20. PubMed ID: 21468007 [TBL] [Abstract][Full Text] [Related]
12. Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies. Shi Q; Wilcox DA; Fahs SA; Weiler H; Wells CW; Cooley BC; Desai D; Morateck PA; Gorski J; Montgomery RR J Clin Invest; 2006 Jul; 116(7):1974-82. PubMed ID: 16823491 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors. Chuah MK; Schiedner G; Thorrez L; Brown B; Johnston M; Gillijns V; Hertel S; Van Rooijen N; Lillicrap D; Collen D; VandenDriessche T; Kochanek S Blood; 2003 Mar; 101(5):1734-43. PubMed ID: 12406898 [TBL] [Abstract][Full Text] [Related]
14. Anti-CD3 antibodies modulate anti-factor VIII immune responses in hemophilia A mice after factor VIII plasmid-mediated gene therapy. Peng B; Ye P; Rawlings DJ; Ochs HD; Miao CH Blood; 2009 Nov; 114(20):4373-82. PubMed ID: 19770362 [TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy of adeno-associated virus serotypes 8 and 9 in hemophilia a dogs and mice. Sarkar R; Mucci M; Addya S; Tetreault R; Bellinger DA; Nichols TC; Kazazian HH Hum Gene Ther; 2006 Apr; 17(4):427-39. PubMed ID: 16610930 [TBL] [Abstract][Full Text] [Related]
16. Transient blockade of the inducible costimulator pathway generates long-term tolerance to factor VIII after nonviral gene transfer into hemophilia A mice. Peng B; Ye P; Blazar BR; Freeman GJ; Rawlings DJ; Ochs HD; Miao CH Blood; 2008 Sep; 112(5):1662-72. PubMed ID: 18574023 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant. McIntosh J; Lenting PJ; Rosales C; Lee D; Rabbanian S; Raj D; Patel N; Tuddenham EG; Christophe OD; McVey JH; Waddington S; Nienhuis AW; Gray JT; Fagone P; Mingozzi F; Zhou SZ; High KA; Cancio M; Ng CY; Zhou J; Morton CL; Davidoff AM; Nathwani AC Blood; 2013 Apr; 121(17):3335-44. PubMed ID: 23426947 [TBL] [Abstract][Full Text] [Related]
18. Liver-restricted expression of the canine factor VIII gene facilitates prevention of inhibitor formation in factor VIII-deficient mice. Ishiwata A; Mimuro J; Mizukami H; Kashiwakura Y; Takano K; Ohmori T; Madoiwa S; Ozawa K; Sakata Y J Gene Med; 2009 Nov; 11(11):1020-9. PubMed ID: 19757487 [TBL] [Abstract][Full Text] [Related]
19. Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia A. Reipert BM; Ahmad RU; Turecek PL; Schwarz HP Thromb Haemost; 2000 Nov; 84(5):826-32. PubMed ID: 11127864 [TBL] [Abstract][Full Text] [Related]
20. In vivo evaluation of an adenoviral vector encoding canine factor VIII: high-level, sustained expression in hemophiliac mice. Gallo-Penn AM; Shirley PS; Andrews JL; Kayda DB; Pinkstaff AM; Kaloss M; Tinlin S; Cameron C; Notley C; Hough C; Lillicrap D; Kaleko M; Connelly S Hum Gene Ther; 1999 Jul; 10(11):1791-802. PubMed ID: 10446919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]